Trial Profile
Microdose clinical trial for prediction of interindividual variability of PK and PD in patients administered with atorvastatin, pravastatin, rosuvastatine or telmisartan.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Pravastatin (Primary) ; Rosuvastatin (Primary) ; Telmisartan (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacogenomic; Pharmacokinetics
- 04 Feb 2010 New trial record